JDRF has announced a partnership with Arecor Ltd to support development of a stable, rapid-acting, ultra-concentrated insulin. Improved insulins would enable the miniaturization of next-generation insulin-delivery devices for people with Type 1 diabetes. The aim is to advance the pre-clinical trials of read more »